1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD229 CAR T cell therapy for the treatment of relapsed B cell lymphoma
    Meeting Abstract

    Olson, M.; Luetkens, T.; Iglesias, F.; Radhakrishnan, S.; Law, J. Y.; Avila, S.; Mause, E. V.; Camp, N. J.; Morales, E.; Rapoport, A. P.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Pediatric patients with immune thrombocytopenic purpura have a dysbiotic gut microbiome at time of diagnosis
    Meeting Abstract

    Oved, J. H.; Elgarten, C. W.; Daniel, S. G.; Denu, L.; Silverman, M.; Bittinger, K.; Olson, T. S.; Lambert, M. P.
    Blood (2021)

    Fulltext@MSK | Save
  • Allogeneic transplantation in fit older adults is feasible and encouragingly efficacious. Post remission data from the prospective ECOG-ACRIN (E2906) clinical study
    Meeting Abstract

    Ofran, Y.; Sun, Z.; Rowe, J. M.; Claxton, D. F.; Tallman, M. S.; Arber, D. A.; Melnick, A.; Levine, R. L.; Paietta, E.; Godwin, J. E.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Enrollment characteristics and outcomes of Hispanic and Black AYA ALL patients enrolled on a US Intergroup clinical trial: A comparison of the CALGB 10403 (alliance) cohort with us population-level data
    Meeting Abstract

    Muffly, L.; Yin, J.; Jacobson, S.; Advani, A.; Luger, S. M.; Tallman, M. S.; Litzow, M. R.; Foster, M. C.; Appelbaum, F. R.; Larson, R. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Complete remission with devimistat (CPI-613) in refractory Burkitt lymphoma
    Meeting Abstract

    Nikolaenko, L.; Pardee, T.; Steiner, R.; Abramson, J. S.; Horwitz, S. M.; Matasar, M. J.; Owens, C.; Rodriguez-Rivera, I.; Straus, D. J.; Luther, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • High throughput single-cell simultaneous genotyping and chromatin accessibility reveals genotype to phenotype relationship in human myeloproliferation
    Meeting Abstract

    Myers, R. M.; Izzo, F.; Prieto, T.; Mimitou, E.; Raviram, R.; Chaligne, R.; Hoffman, R.; Stahl, M.; Abdel-Wahab, O.; Marcellino, B.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • A new role for the SRC family member HCK as a driver of BCR/SYK signaling in MYD88 mutated lymphomas
    Meeting Abstract

    Munshi, M.; Liu, X.; Kofides, A.; Tsakmaklis, N.; Demos, M. G.; Guerrera, M. L.; Hunter, Z. R.; Palomba, M. L.; Argyropoulos, K. V.; Patterson, C. J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Graded cardiac response criteria for AL amyloidosis: The impact of depth of cardiac response on survival
    Meeting Abstract

    Muchtar, E.; Dispenzieri, A.; Wisniowski, B.; Palladini, G.; Milani, P.; Merlini, G.; Schönland, S.; Veelken, K.; Hegenbart, U.; Kumar, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Graded renal response criteria for light chain (AL) amyloidosis
    Meeting Abstract

    Muchtar, E.; Wisniowski, B.; Palladini, G.; Milani, P.; Merlini, G.; Schönland, S.; Veelken, K.; Hegenbart, U.; Dispenzieri, A.; Kumar, S.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Phase II trial of eprenetapopt (APR-246) in combination with azacitidine (AZA) as maintenance therapy for TP53 mutated AML or MDS following allogeneic stem cell transplantation (SCT)
    Meeting Abstract

    Mishra, A.; Tamari, R.; DeZern, A. E.; Byrne, M. T.; Gooptu, M.; Chen, Y. B.; Deeg, H. J.; Gallacher, P.; Wennborg, A.; Hickman, D. K.; more...
    Blood (2021)

    Fulltext@MSK | Save